Superbug Sickens Dozens in Illinois

A single hospital was at the epicenter of an outbreak of antibiotic-resistant bacteria.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The suburban Chicago hospital where dozens of patients were infected with CREWIKIMEDIA, ZOL87Nearly 50 people in the Chicago area have turned up with infections involving a relatively new and virulent bacterium, and a suburban hospital appears to be a major contributor to the outbreak. The US Centers for Disease Control and Prevention (CDC) reported last week (January 3) that 44 people in northeastern Illinois were infected with carbapenem-resistant Enterobacteriaceae (CRE), a bacterium that is highly resistant to treatment, and one the agency last year deemed an urgent threat to public health. Of the 44 affected, 38 were patients who underwent endoscopic procedures involving the pancreas or bile ducts at Advocate Lutheran General Hospital in Park Ridge, IL, between January and September 2013.

“It’s the largest outbreak that we’ve seen in the U.S. of this bacteri[um] ever,” Alex Kallen, a CDC infectious disease doctor involved with the investigation of the outbreak, told CBS Chicago.

In total, 243 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) at Advocate Lutheran were exposed to the bacterium, but most people were only “colonized,” not infected with the pathogen. According to the hospital, 28 patients tested positive for the microbe, but did not show signs of an infection, and 10 others did exhibit symptoms of infection. “The design of the ERCP endoscopes might pose a particular challenge for cleaning and disinfection,” according to the CDC report.

In the U.S., CRE was first reported in 2009, and through 2012, only 27 infected patients have been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS